Dieter Lang

SUBSTITUTED OXOPYRIDINE DERIVATIVES

PHARMACEUTICAL DRY POWDER INHALATION FORMULATION

TREATMENT OF CARDIOPULMONARY DISORDERS

Treatment of cardiopulmonary disorders

SUBSTITUTED OXOPYRIDINE DERIVATIVES

SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES

SUBSTITUTED OXOPYRIDINE DERIVATIVES

AZABICYCLIC CARBAMATES AND THEIR USE AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS

Substituted oxopyridine derivatives

2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides

Substituted oxopyridine derivatives

Substituted piperidinyl tetrahydroquinolines

Substituted piperidinyl tetrahydroquinolines

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

HYDROXYALKYL-SUBSTITUTED PHENYLTRIAZOLE DERIVATIVES AND USES THEREOF

5-aminotetrahydroquinoline-2-carboxylic acids and their use

AMINO-SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF

SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF

HETEROBICYCLICALLY SUBSTITUTED 4-OXOBUTANE ACID DERIVATIVES AND USE THEREOF

CHIRAL 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND USE THEREOF

2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES

6-CHLORINE-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE CARBOXAMIDES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS

ENANTIOMERS OF THE N-(2-AMINO-5-FLUORO-2-METHYLPENTYL)-8-[(2,6-DIFLUOROBENZYL)OXY]-2-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE, AS WELL AS OF THE DI- AND TRIFLUORO DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACIDS AND THEIR USE

3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines

Substituted piperidinyl tetrahydroquinolines

SUBSTITUTED BIPIPERIDINYL DERIVATIVES

Substituted piperidinyltetrahydroquinolines

Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof

Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof

BENZYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF

Substituted annulated triazines and use thereof

5-aminotetrahydroquinoline-2-carboxylic acids and their use

Substituted annellated pyrimidines and use thereof

Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

Substituted azabicycles and use thereof

SUBSTITUTED ANNULATED PYRIMIDINES AND TRIAZINES, AND USE THEREOF

Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors

Trifluoromethyl-substituted fused pyrimidines and their use

HETEROARYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS

SUBSTITUTED IMIDAZOPYRIDINES AND IMIDAZOPYRIDAZINES AND THE USE THEREOF

Substituted aryloxazoles and their use

Fluoroalkyl-substituted pyrazolopyridines and use thereof

5-aminotetrahydroquinoline-2-carboxylic acids and their use

Substituted annellated pyrimidines and use thereof

Substituted fused imidazoles and pyrazoles and use thereof

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS

17Beta-Alkyl-17Alpha-oxy-estratrienes

SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF

3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof

Substituted pyrazolamides and their use

Substituted aryloxazoles and their use

Substituted tricyclic compounds and methods of use thereof

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

Substituted oxazolidinones and their use

Substituted oxazolidinones and their use

Lactam-substituted dicarboxylic acids and use thereof

Substituted azaquinazolines having an antiviral action

Substituted dibenzoic acid derivatives and use thereof

Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof

Dicarboxylic acid derivatives and their use

4-Chromenonyl-1,4-dihydropyridines and their use

Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof

Substituted quinolones III

Substituted arylsulfonamides as antiviral agents

MORPHINE-BRIDGED INDAZOLE DERIVATIVES

Substituted phenylamino-pyrimidines

Novel Pyrimidine Derivatives and their Use

Substituted quinolones II

Phenylthioacetic Acid Derivatives and Use Thereof

Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular Diseases

Heterocyclyamide-substituted imidazoles

Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors

Substituted azaquinazolines having an antiviral action

Antiviral 4-aminocarbonylamino-substituted imidazole compounds

Substituted quinolones

Substituted dihydroquinazolines II

Substituted dihydroquinazolines

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors

Substituted quinazolines as antiviral agents, especially against cytomegaloviruses

Sulfonamide-substituted pyrazolopyridine compounds

Carbamate-substituted pyrazolopyridine-derivatives

Morpoline-bridged indazole derivatives

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

4-amino-substituted pyrimidine derivatives

Medical uses of carbamate-substituted pyrazolo-pyridine derivatives

Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives

Sulfonate substituted pyrazol pyridine derivatives

Lactam-substituted pyrazolopyridine derivatives

Substituted dihydroquinazolines